Searching for a home, the real commute tool from Realtor.com,

lets you find homes right where you need to be.

Find a home 10 minutes from work, 15 from school, and 20 from grandmas.

With over half a million new listings every month,

you're just minutes from finding your perfect home on Realtor.com.

Trust the number one site Real Estate Professionals Trust.

Search now on Realtor.com.

Based on average

new for sale and rental listings July 24th through June 2025. Number one trusted based on

August 2025 proprietary survey among real estate professionals. Here is your morning brief

for Thursday, April 2nd. I'm Luke Vargas for the Wall Street Journal.

In an address to the nation last night, President Trump made his case that the month-old war in Iran was in America's interests and that any economic pain stemming from it would be over soon.

Trump also predicted that stock prices will rapidly go back up and said the U.S. economy is, quote, strong and

improving by the day. However, investors seem to be bracing for continued disruption.

U.S. stock futures began sliding during Trump's speech and remained down this morning.

Asian markets fell today, while European shares are also mainly lower in midday trading.

Eli Lilly has won U.S. regulatory approval for its once daily GLP1 pill. Foundaio will be going

up against the pill version of Novo Nordisk's Uigovi, which went on sale at the start of the year

in what turned out to be one of the best drug launches in history.

Eli Lilly's GLP1 injections now outsell those pioneered by Novo Nordisk, and analysts are betting that Foundeo will generate about $21 billion in global sales for Lilly by 2030, compared with $4 billion for the WegoVPill.

And we are exclusively reporting that the Trump administration could announce changes to

steel and aluminum tariffs as soon as this week. The shift could see a 25% tariff applied

...